Co-Diagnostics reported record fourth-quarter results, driven by demand for its Logix Smart COVID-19 Test. Revenue reached $27.1 million, and pre-tax income was $15.8 million.
Co-Diagnostics reported record quarterly revenue of $27.1 million.
Pre-tax income for the quarter was $15.8 million.
Demand for Logix Smart COVID-19 Test drove record sales.
The company anticipates continued demand for its COVID-19 tests and other diagnostic products in 2021.
Co-Diagnostics anticipates continued demand for its COVID-19 tests and other diagnostic products as testing becomes a part of the long-term protocol for many organizations. The company expects its distribution platform, production capacity, product reliability, and ongoing product innovation will position it for additional growth throughout the world.